RGACX
Price
$75.80
Change
+$0.53 (+0.70%)
Updated
Jan 22 closing price
Net Assets
310.06B
RGAEX
Price
$77.42
Change
+$0.53 (+0.69%)
Updated
Jan 22 closing price
Net Assets
310.06B
Ad is loading...

RGACX vs RGAEX

Header iconRGACX vs RGAEX Comparison
Open Charts RGACX vs RGAEXBanner chart's image
American Funds Growth Fund of Amer R3
Price$75.80
Change+$0.53 (+0.70%)
VolumeN/A
Net Assets310.06B
American Funds Growth Fund of Amer R4
Price$77.42
Change+$0.53 (+0.69%)
VolumeN/A
Net Assets310.06B
RGACX vs RGAEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGACX vs. RGAEX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGACX is a StrongBuy and RGAEX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX (310B) and RGAEX (310B) have equal amount of cash in the bank . RGAEX pays higher dividends than RGACX: RGAEX (0.44) vs RGACX (0.25). RGACX was incepted earlier than RGAEX: RGACX (23 years) vs RGAEX (23 years). RGACX (31.00) and RGAEX (31.00) have comparable annual turnover. RGACX (250) and RGAEX (250) have matching initial minimum investment requirements. RGAEX (21.53) and RGACX (20.97) have marching annual gain over last year. RGAEX (47.49) and RGACX (45.22) have equivalent 5 years return.
RGACXRGAEXRGACX / RGAEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD4.5564.58499%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets310B310B100%
Annual Yield % from dividends0.250.4458%
Returns for 1 year20.9721.5397%
Returns for 3 years19.1020.2894%
Returns for 5 years45.2247.4995%
Returns for 10 years78.8982.0996%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AXSM96.184.25
+4.62%
Axsome Therapeutics
IR94.082.20
+2.39%
Ingersoll Rand
COLL33.19-0.16
-0.48%
Collegium Pharmaceutical
VTVT13.97-0.09
-0.60%
vTv Therapeutics
DSGN4.87-0.19
-3.75%
Design Therapeutics